Skip to main content
Clinical Trials/NCT05686395
NCT05686395
Completed
N/A

Comparative Study of Analgesic Efficacy of Ultrasound Guided Interscalene Block Versus Combined Shoulder Anterior Capsular Block and Suprascapular Nerve Block for Arthroscopic Shoulder Surgeries.

Tanta University1 site in 1 country90 target enrollmentJanuary 23, 2023

Overview

Phase
N/A
Intervention
Ultrasound-guided Interscalene Block group
Conditions
Post Operative Pain
Sponsor
Tanta University
Enrollment
90
Locations
1
Primary Endpoint
post operative analgesic consumption
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study will be conducted to compare the perioperative analgesic efficacy of ultrasound - guided interscalene brachial plexus block versus combined shoulder anterior capsular block and anterior suprascapular nerve block for arthroscopic shoulder surgeries.

Registry
clinicaltrials.gov
Start Date
January 23, 2023
End Date
August 11, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hosameldin Ibrahim Ibrahim Elsayed Eldib

ASSISTANT LECTURER OF ANESTHESIA AND INTENSIVE CARE AND PAIN MEDICINE

Tanta University

Eligibility Criteria

Inclusion Criteria

  • Patients aged 20-65 years of both sexes, with American Society of Anesthesiologists (ASA) physical status I or II admitted for arthroscopic shoulder surgery.

Exclusion Criteria

  • Patient refusal.
  • Uncooperative patient.
  • Patient with neurological deficit.
  • Patients with respiratory disorders.
  • Patient with bleeding disorders.
  • Infection at the block injection site.
  • Patients with history of allergy to local anesthetics.

Arms & Interventions

group 1 Ultrasound-guided Interscalene Block group

In this group, ultrasound-guided ISB will be done using 10 ml of bupivacaine 0.25%.

Intervention: Ultrasound-guided Interscalene Block group

group 1 Ultrasound-guided Interscalene Block group

In this group, ultrasound-guided ISB will be done using 10 ml of bupivacaine 0.25%.

Intervention: Bupivacaine

group 2 Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block

, ultrasound-guided SHAC block will be done using 10 ml of bupivacaine 0.25% injected in the interfacial plane between deltoid and subscapular muscle and 10 ml of bupivacaine 0.25% injected in the pericapsular space. Ultrasound-guided SSN block will be done using 10 ml of bupivacaine 0.25% injected at sub omohyoid space.

Intervention: Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block

group 2 Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block

, ultrasound-guided SHAC block will be done using 10 ml of bupivacaine 0.25% injected in the interfacial plane between deltoid and subscapular muscle and 10 ml of bupivacaine 0.25% injected in the pericapsular space. Ultrasound-guided SSN block will be done using 10 ml of bupivacaine 0.25% injected at sub omohyoid space.

Intervention: Bupivacaine

Outcomes

Primary Outcomes

post operative analgesic consumption

Time Frame: 24 hours after surgery

The first 24 hours post operative analgesic consumption

Secondary Outcomes

  • Visual Analogue score (VAS) in the first 24 hours after surgery(first 24 hours after surgery)
  • Patient satisfaction score(first 24 hours after surgery)
  • The incidence of hemi diaphragmatic paralysis(immediately before block and immediately after procedure)

Study Sites (1)

Loading locations...

Similar Trials